University of Chicago, Anesthesia & Critical Care
Chicago, Illinois, 60637, United States
NCT Number: NCT00000255
The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To examine differential acute tolerance development to effects of nitrous oxide in humans.
Looking for future studies?
Notify Me21 year–37 year
All sexes
Interventional
Phase 2
Chicago, Illinois, 60637, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Please contact site for information.
Time frame: 25, 70, & 115 min of inhalation and 40 min post
Subjects will inhale varying conc of nitrous oxide for 120 min with cold immersion of forearm at 25, 70, and 115 min and 40 min after inhalation. Pain intensity and bothersomeness will be assessed at each immersion.
University of Chicago
Other
Differential Acute Tolerance Development to Effects of Nitrous Oxide
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00000250
Agnosia, Chemically-Induced Disorders
Chicago, Illinois, United States
View Trial DetailsNCT00000252
Agnosia, Chemically-Induced Disorders
Chicago, Illinois, United States
View Trial DetailsNCT00000262
Agnosia, Chemically-Induced Disorders
Chicago, Illinois, United States
View Trial DetailsNCT06023459
Chemically-Induced Disorders, Mental Disorders
El Dorado, Arkansas, United States
View Trial Details